Sanofi SA (SNY)
46.32
+0.91
(+2.00%)
USD |
NASDAQ |
Apr 19, 16:00
46.29
-0.03
(-0.06%)
After-Hours: 16:47
Sanofi Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | 4.074B |
| June 30, 2021 | 12.68B |
| June 30, 2020 | 4.324B |
| June 30, 2019 | 3.571B |
| June 30, 2018 | 2.117B |
| June 30, 2017 | 2.812B |
| June 30, 2016 | 2.945B |
| June 30, 2015 | 3.763B |
| June 30, 2014 | 3.476B |
| June 30, 2013 | 2.645B |
| June 30, 2012 | 5.556B |
| Date | Value |
|---|---|
| June 30, 2011 | 5.626B |
| June 30, 2010 | 5.565B |
| June 30, 2009 | 5.969B |
| June 30, 2008 | 5.064B |
| June 30, 2007 | 4.107B |
| June 30, 2006 | 3.731B |
| June 30, 2005 | 4.265B |
| June 30, 2004 | 921.24M |
| June 30, 2003 | 862.07M |
| June 30, 2002 | 358.63M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
3.571B
Minimum
Jun 2019
12.68B
Maximum
Jun 2021
6.163B
Average
4.199B
Median
Cash from Operations (Quarterly) Benchmarks
| AstraZeneca PLC | 2.38B |
| GSK PLC | 3.899B |
| Novo Nordisk A/S | 1.302B |
| Regeneron Pharmaceuticals Inc | 1.090B |
| Inhibrx Inc | -56.82M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow Yield | 16.78% |